[go: up one dir, main page]

FI970068A0 - Menetelmä 2-(1-atsabisyklo/2,2,2/okt-3-yyli)-2,4,5,6-tetrahydro-1H-bens/de/isokinolin-1-onin ja välituotteen valmistamiseksi - Google Patents

Menetelmä 2-(1-atsabisyklo/2,2,2/okt-3-yyli)-2,4,5,6-tetrahydro-1H-bens/de/isokinolin-1-onin ja välituotteen valmistamiseksi

Info

Publication number
FI970068A0
FI970068A0 FI970068A FI970068A FI970068A0 FI 970068 A0 FI970068 A0 FI 970068A0 FI 970068 A FI970068 A FI 970068A FI 970068 A FI970068 A FI 970068A FI 970068 A0 FI970068 A0 FI 970068A0
Authority
FI
Finland
Prior art keywords
isoquinolin
azabicyclo
tetrahydro
oct
benzene
Prior art date
Application number
FI970068A
Other languages
English (en)
Swedish (sv)
Other versions
FI120198B (fi
FI970068A7 (fi
Inventor
Charles Alois Dvorak
Bruce Andrew Kowalczyk
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23040964&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI970068(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of FI970068A7 publication Critical patent/FI970068A7/fi
Publication of FI970068A0 publication Critical patent/FI970068A0/fi
Application granted granted Critical
Publication of FI120198B publication Critical patent/FI120198B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI970068A 1994-07-08 1997-01-07 Menetelmä 2-(1-atsabisyklo[2.2.2]okt-3-yyli)-2,4,5,6-tetrahydro-1H-bens[de]isokinolin-1-onin ja välituotteen valmistamiseksi FI120198B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US27271594 1994-07-08
US08/272,715 US5567818A (en) 1994-07-08 1994-07-08 Processes for preparing 2-(1-azabicyclo[2.2.2]oct-3-yl)-1H-benz[de] isoquinolin-1-one derivatives and intermediates useful therein
PCT/EP1995/002556 WO1996001824A1 (en) 1994-07-08 1995-07-01 Process for the preparation of 2-(1-azabicyclo(2.2.2)oct-3-yl) -2,4,5,6-tetrahydro-1h-benz(de)isoquinolin-1-one and intermediate product
EP9502556 1995-07-01

Publications (3)

Publication Number Publication Date
FI970068A7 FI970068A7 (fi) 1997-01-07
FI970068A0 true FI970068A0 (fi) 1997-01-07
FI120198B FI120198B (fi) 2009-07-31

Family

ID=23040964

Family Applications (1)

Application Number Title Priority Date Filing Date
FI970068A FI120198B (fi) 1994-07-08 1997-01-07 Menetelmä 2-(1-atsabisyklo[2.2.2]okt-3-yyli)-2,4,5,6-tetrahydro-1H-bens[de]isokinolin-1-onin ja välituotteen valmistamiseksi

Country Status (16)

Country Link
US (1) US5567818A (fi)
EP (1) EP0770077B1 (fi)
JP (1) JP2898758B2 (fi)
CN (1) CN1048727C (fi)
AT (1) ATE205845T1 (fi)
AU (1) AU2979995A (fi)
BR (1) BR9508249A (fi)
CL (2) CL2004001244A1 (fi)
CY (1) CY2342B1 (fi)
DE (1) DE69522808T2 (fi)
DK (1) DK0770077T3 (fi)
ES (1) ES2162929T3 (fi)
FI (1) FI120198B (fi)
MX (1) MX9700157A (fi)
PT (1) PT770077E (fi)
WO (1) WO1996001824A1 (fi)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2406677C (en) 2000-04-20 2008-07-15 Masonite Corporation Reverse molded panel
US8598219B2 (en) 2003-01-30 2013-12-03 Helsinn Healthcare Sa Liquid pharmaceutical formulations of palonosetron
JO2735B1 (en) * 2003-01-30 2013-09-15 هيلسين هيلث كير أس ايه. Liquid pharmaceutical formations of balloonosterone
US8614225B2 (en) * 2006-08-30 2013-12-24 Dr. Reddy's Laboratories Limited Process for the purification of palonosetron or its salt
EP1966197A2 (en) * 2006-10-23 2008-09-10 Sicor, Inc. Processes for preparing palonosetron salts
WO2008073757A1 (en) * 2006-12-07 2008-06-19 Helsinn Healthcare Sa Crystalline and amorphous forms of palonosetron hydrochloride
EP2155199A4 (en) * 2007-05-29 2011-08-24 Chemagis Ltd NEW PALONOSETRONIC SALTS AND METHOD FOR THEIR PREPARATION AND CLEANING
WO2009010987A1 (en) * 2007-07-19 2009-01-22 Natco Pharma Limited An improved process for the preparation of pure palonosetron hydrochloride
AR069625A1 (es) * 2007-12-13 2010-02-03 Glenmark Generics Ltd Base libre de palonosetron y procedimiento para su preparacion
WO2009087643A1 (en) * 2008-01-11 2009-07-16 Natco Pharma Limited Novel crystalline forms of palonosetron hydrochloride
WO2009136405A1 (en) * 2008-05-05 2009-11-12 Natco Pharma Limited High purity palonosetron base and its solid state characteristics
WO2010056656A2 (en) * 2008-11-11 2010-05-20 Dr. Reddy's Laboratories Ltd. Preparation of crystalline palonosetron hydrochloride
CN101851233B (zh) * 2009-04-03 2013-03-06 四川滇虹医药开发有限公司 盐酸帕洛诺司琼和其前体化合物及制备
US20120267533A1 (en) 2009-06-30 2012-10-25 Ranbaxy Laboratories Limited Processes for the preparation of form i and form ii of palonosetron hydrochloride
WO2011013095A1 (en) 2009-07-31 2011-02-03 Ranbaxy Laboratories Limited Processes for the preparation of palonosetron
JP2014070036A (ja) * 2012-09-28 2014-04-21 Mitsubishi Gas Chemical Co Inc １，８−テトラリンジカルボン酸無水物の製造方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4007191A (en) * 1975-10-14 1977-02-08 E. R. Squibb & Sons, Inc. 2-(Piperidinyl or tetrahydropyridinyl)-alkyl)-2,3-dihydro-3-hydroxy-1H-benz(DE)isoquinolin-1-ones
FI98367C (fi) * 1989-11-28 1997-06-10 Syntex Inc Menetelmä uusien terapeuttisesti käyttökelpoisten trisyklisten, typpipitoisten yhdisteiden valmistamiseksi
US5202318A (en) * 1990-05-14 1993-04-13 Syntex (U.S.A.) Inc. Tricyclic compounds acting at serotonin receptor subtypes

Also Published As

Publication number Publication date
BR9508249A (pt) 1998-01-06
EP0770077A1 (en) 1997-05-02
CN1152313A (zh) 1997-06-18
FI120198B (fi) 2009-07-31
JP2898758B2 (ja) 1999-06-02
DE69522808T2 (de) 2002-04-04
CN1048727C (zh) 2000-01-26
AU2979995A (en) 1996-02-09
EP0770077B1 (en) 2001-09-19
MX9700157A (es) 1997-04-30
US5567818A (en) 1996-10-22
CY2342B1 (en) 2004-02-06
CL2007001958A1 (es) 2008-02-22
FI970068A7 (fi) 1997-01-07
DK0770077T3 (da) 2002-01-14
WO1996001824A1 (en) 1996-01-25
CL2004001244A1 (es) 2005-04-15
PT770077E (pt) 2002-02-28
ATE205845T1 (de) 2001-10-15
JPH09508645A (ja) 1997-09-02
DE69522808D1 (de) 2001-10-25
ES2162929T3 (es) 2002-01-16

Similar Documents

Publication Publication Date Title
FI970068A0 (fi) Menetelmä 2-(1-atsabisyklo/2,2,2/okt-3-yyli)-2,4,5,6-tetrahydro-1H-bens/de/isokinolin-1-onin ja välituotteen valmistamiseksi
DZ2037A1 (fr) Amines bicyclique utiles comme insecticides, procédé pour leur préparation et compositions les contenant.
FI960949A0 (fi) Uusi lipaasi, lipaasia tuottavat mikro-organismit, menetelmä lipaasin tuottamiseksi ja lipaasin käyttö
MA23452A1 (fr) Procede de preparation d'agents antiparasitaires consistant en derives d'avermectines et de milbemycines.
MA23831A1 (fr) Derives de quinazoline, procede pour leur preparation et composition les contenant
FI962599A0 (fi) Enantioselektiivinen menetelmä kiraalisten triaryylijohdannaisten ja niiden valmistuksessa käytettävien kiraalisten välituotteiden valmistamiseksi
NO179674C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, heterosykliske N-oksidderivater av substituerte benzo[5,6Åsyklo-heptapyridiner
DK0787115T3 (da) Fremgangsmåde til fremstilling af 4a,5,9,10,11,12-hexahydro-6H-benzofuro[3a,3,2-ef][2]benzazepinderivater
FI911083A7 (fi) Menetelmä kolinergisina aineina käyttökelpoisten 1-atsabisyklo/2.2.1/heptaani- tai -/2.2.2/oktaani-3-oni-O-oksiimien valmistamiseksi
MA21748A1 (fr) Procede d'obtention de nouvelles tetrahydroimidazo [1,4] bensodiazepin-2-thiones antivirales et leur preparation .
IE870112L (en) Fused benzazepines and intermediates thereof
DE69020172D1 (de) Verfahren zur Herstellung von epsilon-Caprolactam.
BE882420A (fr) Nouveaux derives d'alpha-(3,4-dichlorophenyl)-imidazoline ou pyrimidine-2-methanols utiles notamment comme agents antisecretoires et leur procede de preparation
FR2595352B1 (fr) Derives de l'indole utiles comme medicaments et procede et intermediaires pour leur preparation
NO174053C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive R(-) 3-kinuklidinol-derivater
DE59603028D1 (de) Verfahren zur Herstellung von 3-Chlorphthalsäureanhydrid
FR2603276B1 (fr) Procede de production de glycols et de glycerol par hydrogenolyse d'alditols
FI112482B (fi) 6,7,8,9-tetrahydro-1H-pyrrolo[3,2-h]isokinoliini- ja 1,6,7,8-tetrahydrobentso[2,1-b;3,4-c]-2,3-dioni-3-oksiimijohdannaisia, menetelmä niiden valmistamiseksi ja niiden käyttö
IL118769A0 (en) Process for stereoselective preparation of (-)3a,6,6,9a-tetramethyl-perhydronaphtho[2,1-b]furan
MA23081A1 (fr) Procede de preparation de derives d'indolone
DE59104391D1 (de) Verfahren zur Behandlung von Faserverbundwerkstoffen.
DK0796256T3 (da) Fremgangsmåde til fremstilling af ranitidin
FR2676229B1 (fr) Procede de preparation du [3ar-(3aalpha,5abeta,9aalpha,9bbeta)]-dodecahydro-3a,6,6,9a-tetramethylnaphto [2,1-b] furane.
DE69007028D1 (de) Verfahren zur Herstellung von 3,4-Epoxybutyrat und Zwischenprodukte dafür.
FR2713241B1 (fr) Procédé dde préparation de liposomes par voie enzymatique.

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 120198

Country of ref document: FI

MA Patent expired